Next 10 |
RALEIGH, NC / ACCESSWIRE / May 30, 2023 / 9 Meters Biopharma, Inc. (NASDAQ:NMTR), a clinical-stage company pioneering novel treatments for people with rare or debilitating digestive diseases, today announced that the Board of Directors has accepted the resignation of John Temperato as President ...
2023-05-15 17:40:12 ET 9 Meters Biopharma press release ( NASDAQ: NMTR ): Q1 GAAP EPS of -$1.02 misses by $0.24 . As of March 31, 2022, the Company's unrestricted cash and cash equivalents totaled approximately $6.9 million, compared to approximately $12.6 million as o...
RALEIGH, NC / ACCESSWIRE / May 15, 2023 / 9 Meters Biopharma, Inc. (Nasdaq:NMTR), a clinical-stage company pioneering novel treatments for people with rare or debilitating digestive diseases, today provided a business update and announced financial results for the first quarter ended March 31, 2...
2023-04-05 09:25:05 ET 9 Meters Biopharma ( NASDAQ: NMTR ) expects to file an application to the U.S. Food and Drug Administration (FDA) in H2 2023 for starting a trial of its obesity therapy NM-136. The company said it received a written response from the FDA on a r...
2023-04-05 08:31:04 ET Secoo Holding ( SECO ) -22% . The NFT Gaming Company ( NFTG ) -16% . Assure Holdings ( IONM ) -12% . Bullfrog AI Holdings ( BFRG ) -11% . Alarum Technologies ( ALAR ) -10% . Guardforce AI ( GFAI ) -8%...
RALEIGH, NC / ACCESSWIRE / April 5, 2023 / 9 Meters Biopharma, Inc. (NASDAQ:NMTR), a clinical-stage company pioneering novel treatments for people with rare or debilitating digestive diseases, today announced receipt of a written response from the U.S. Food and Drug Administration (FDA) on the r...
2023-03-28 08:52:14 ET 9 Meters Biopharma press release ( NASDAQ: NMTR ): Q4 GAAP EPS of -$0.92 misses by $0.12 . As of December 31, 2022, the Company had total cash and cash equivalents of approximately $29.7 million, compared to approximately $39.4 million as of Se...
RALEIGH, NC / ACCESSWIRE / March 28, 2023 / 9 Meters Biopharma, Inc. (NASDAQ:NMTR), a clinical-stage company pioneering novel treatments for people with rare or debilitating digestive diseases, today provided an overview of its recent achievements, upcoming milestones, and financial results for ...
RALEIGH, NC / ACCESSWIRE / March 15, 2023 / 9 Meters Biopharma, Inc. (NASDAQ:NMTR), a clinical-stage company pioneering novel treatments for people with rare or debilitating digestive diseases, announced today the closing of its previously announced registered direct offering of 3,125,000 shares...
2023-03-14 08:34:23 ET GitLab ( GTLB ) -30% on Q4 earnings release . Cingulate ( CING ) -11% . 9 Meters Biopharma ( NMTR ) -9% after proposes to raise $5M in stock offering . BigBear.ai ( BBAI ) -9% on Q4 earnings release . B...
News, Short Squeeze, Breakout and More Instantly...
9 Meters Biopharma Inc. Company Name:
NMTR Stock Symbol:
NASDAQ Market:
RALEIGH, NC / ACCESSWIRE / May 30, 2023 / 9 Meters Biopharma, Inc. (NASDAQ:NMTR), a clinical-stage company pioneering novel treatments for people with rare or debilitating digestive diseases, today announced that the Board of Directors has accepted the resignation of John Temperato as President ...
RALEIGH, NC / ACCESSWIRE / May 15, 2023 / 9 Meters Biopharma, Inc. (Nasdaq:NMTR), a clinical-stage company pioneering novel treatments for people with rare or debilitating digestive diseases, today provided a business update and announced financial results for the first quarter ended March 31, 2...
RALEIGH, NC / ACCESSWIRE / April 5, 2023 / 9 Meters Biopharma, Inc. (NASDAQ:NMTR), a clinical-stage company pioneering novel treatments for people with rare or debilitating digestive diseases, today announced receipt of a written response from the U.S. Food and Drug Administration (FDA) on the r...